EMIS Insights, our proprietary research arm, provides comprehensive industry reports on key emerging markets. Our network of locally based industry experts supplies analysis exclusive to EMIS customers.
Each report contains in-depth analysis of the sector’s importance for the country’s economy, detailed statistics and infographics. The report’s contents include executive summary, sector and subsector overviews, competitive and regulatory environment, as well as thorough company profiles of the top market players.
China’s environmental protection sector remained on its expansion track in 2017. The country invested RMB 8,211bn in fixed assets for water conservancy, environment and utility management in 2017, representing an increase of 19.6% y/y and ...
View more details
The Philippines banking sector remains in a nascent stage of development, and most Filipinos tend to engage in financial activities using less formal channels such as pawnshops. Nonetheless, the banking sector has been expanding its services to ...
View more details
Chile’s banking sector is one of the most developed and competitive in Latin America. It is deep, solvent and highly integrated with the global economy. After two years of deceleration, banking activity has started to gain pace since the second ...
View more details
In 2017, Brazil’s economy exited one of the deepest recessions in decades, and retail sales in the country returned to growth, expanding by 2% y/y in volume terms. Several factors supported the turnaround of the sector, including slowing ...
View more details
India’s is the world’s 10th-largest pharmaceutical market in US dollar terms - with sales of over USD 25bn in 2017 - and the largest generic drug manufacturer and exporter globally. Strong domestic demand and robust exports have ...
View more details
The gross value added (GVA) of the Czech pharmaceutical sector amounted to CZK 19.4bn in 2017, increasing by a real 11.1% y/y. The sector accounted for 0.4% of the GDP that year. The pharmaceutical sector employed 9,855 workers in 2017, accounting ...
View more details
Although the global pharma & healthcare sector is dominated by large multinational companies, mainly from the developed countries, Latin America has been quickly catching up in building a domestic pharmaceutical production base and expanding the ...
View more details
Colombia’s ICT sector claimed a share of 3.1% of its national GVA, or around COP 25.7tn, in 2017, growing 3% compared to 2016 in real terms. In 2017, FDI inflow in TCI exceeded USD 3.4bn, up from USD 1.5bn the previous year, and beating the ...
View more details
As the world’s second largest economy, China relies heavily on coal to ensure the stable operation of its main industries, such as energy and steel. The increasing energy consumption already made China the world’s largest producer and ...
View more details
In the third quarter of 2018, China’s pharmaceutical and medicine production declined by 28.5% y/y to 573,000 tonnes, In 2018, many pharmaceutical producers were affected by the ongoing reform for new chemical drugs classification system, and ...
View more details